BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pramanik S, Pal P, Ray S. Non-alcoholic fatty liver disease in type 2 diabetes: Emerging evidence of benefit of peroxisome proliferator-activated receptors agonists and incretin-based therapies. World J Methodol 2024; 14(2): 91319 [PMID: 38983664 DOI: 10.5662/wjm.v14.i2.91319]
URL: https://www.wjgnet.com/2222-0682/full/v14/i2/91319.htm
Number Citing Articles